Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
leukemia |
| gptkbp:abbreviation |
gptkb:CML
|
| gptkbp:affects |
white blood cells
|
| gptkbp:associatedWith |
gptkb:Philadelphia_chromosome
|
| gptkbp:causedBy |
gptkb:BCR-ABL_fusion_gene
|
| gptkbp:characterizedBy |
uncontrolled proliferation of myeloid cells
|
| gptkbp:diagnosedBy |
blood test
bone marrow biopsy |
| gptkbp:firstDescribed |
1845
|
| https://www.w3.org/2000/01/rdf-schema#label |
Chronic myeloid leukemia
|
| gptkbp:ICD-10_code |
C92.1
|
| gptkbp:medianAge |
55 years
|
| gptkbp:namedAfter |
myeloid cells
|
| gptkbp:period |
accelerated phase
blast crisis chronic phase |
| gptkbp:prevalence |
rare
|
| gptkbp:prognosis |
improved with targeted therapy
|
| gptkbp:riskFactor |
radiation exposure
|
| gptkbp:symptom |
fatigue
splenomegaly weight loss night sweats |
| gptkbp:synonym |
gptkb:chronic_myelogenous_leukemia
|
| gptkbp:treatment |
gptkb:dasatinib
gptkb:imatinib gptkb:nilotinib stem cell transplantation tyrosine kinase inhibitors |
| gptkbp:bfsParent |
gptkb:CML
|
| gptkbp:bfsLayer |
6
|